Syn2bio S.A. (WSE:S2B)
Poland · Delayed Price · Currency is PLN 33.20
+0.20 (0.61%)
Last updated: May 21, 2026, 2:06 PM CET
Syn2bio Market Cap
Syn2bio has a market cap or net worth of 288.06 million as of May 21, 2026.
Market Cap
288.06M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.20
Market Cap Chart
Since April 16, 2026, Syn2bio's market cap has decreased from 311.63M to 288.06M, a decrease of -7.56%. That is a compound annual growth rate of -57.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 288.06M | 2.80% |
| May 19, 2026 | 280.21M | -0.40% |
| May 18, 2026 | 281.34M | -3.04% |
| May 15, 2026 | 290.16M | 4.69% |
| May 14, 2026 | 277.15M | 10.05% |
| May 13, 2026 | 251.84M | 0.52% |
| May 12, 2026 | 250.53M | 3.24% |
| May 11, 2026 | 242.67M | -4.47% |
| May 8, 2026 | 254.02M | 3.93% |
| May 7, 2026 | 244.42M | -3.28% |
| May 6, 2026 | 252.71M | 8.43% |
| May 5, 2026 | 233.07M | -1.11% |
| May 4, 2026 | 235.69M | -6.90% |
| Apr 30, 2026 | 253.14M | 1.79% |
| Apr 29, 2026 | 248.69M | -1.76% |
| Apr 28, 2026 | 253.14M | -9.38% |
| Apr 27, 2026 | 279.33M | -2.14% |
| Apr 24, 2026 | 285.44M | -7.10% |
| Apr 23, 2026 | 307.27M | 4.39% |
| Apr 22, 2026 | 294.35M | -9.38% |
| Apr 21, 2026 | 324.81M | -8.01% |
| Apr 20, 2026 | 353.09M | -5.25% |
| Apr 17, 2026 | 372.65M | 19.58% |
| Apr 16, 2026 | 311.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 523.67M |
| Captor Therapeutics Spolka Akcyjna | 493.02M |
| Bioceltix | 410.21M |
| BIOTON | 372.22M |
| Synthaverse | 212.31M |
| Mabion | 124.45M |
| Molecure | 110.02M |
| NanoGroup | 98.47M |